Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
. (2015) Retraction notice: Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation. International Journal of Speech-Language Pathology 17:1, pages 96-96.
Read now
Read now
Helene Brissart, Elodie Morele, Cedric Baumann, Matthieu Le Perf, Matthieu Leininger, Laetitia Taillemite, Céline Dillier, Sophie Pittion, Elisabeth Spitz & Marc Debouverie. (2013) Cognitive impairment among different clinical courses of multiple sclerosis. Neurological Research 35:8, pages 867-872.
Read now
Read now
George J. Demakis & Robert J. Buchanan. (2010) Rated cognition in nursing home residents with multiple sclerosis: cross-sectional and longitudinal analyses. Disability and Rehabilitation 32:17, pages 1438-1446.
Read now
Read now
Articles from other publishers (36)
Janine Rook, Sara Llufriu, Dörte de Kok & Adrià Rofes. (2023) Language impairments in people with autoimmune neurological diseases: A scoping review. Journal of Communication Disorders 106, pages 106368.
Crossref
Crossref
Damiano Mistri, Laura Cacciaguerra, Paola Valsasina, Elisabetta Pagani, Massimo Filippi & Maria A. Rocca. (2023) Cognitive function in primary and secondary progressive multiple sclerosis: A multiparametric magnetic resonance imaging study. European Journal of Neurology 30:9, pages 2801-2810.
Crossref
Crossref
Amy L. Lebkuecher, Nancy D. Chiaravalloti & Lauren B. Strober. (2021) The role of language ability in verbal fluency of individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders 50, pages 102846.
Crossref
Crossref
Eloi Magnin, Yoshimasa Sagawa, Thierry Moulin & Pierre Decavel. (2020) What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?. European Neurology 83:3, pages 263-270.
Crossref
Crossref
Silvana L. Costa, John DeLuca, Brian M. Sandroff, Yael Goverover & Nancy D. Chiaravalloti. (2017) Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis. Journal of the International Neuropsychological Society 24:2, pages 139-146.
Crossref
Crossref
Alastair Wilkins & Stanley Hawkins. 2018. Progressive Multiple Sclerosis. Progressive Multiple Sclerosis
1
29
.
A. Gouveia, S. P. Dias, T. Santos, H. Rocha, C. R. Coelho, L. Ruano, O. Galego, M. C. Diogo, D. Seixas, M. J. Sá & S. Batista. (2017) Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis. Acta Neurologica Scandinavica 136:2, pages 109-115.
Crossref
Crossref
Bruno Brochet, Christine Lebrun-Frénay, Jérôme de Sèze, Hélène Zéphir, E. Allart, B. Audoin, X. Ayrignac, C. Bensa, A. Blanchard-Dauphin, D. Brassat, C. Carra-Dallière, P. Clavelou, M. Cohen, A. Créange, N. Collongues, M. Debouverie, G. Defer, M. de Sèze, C. Donzé, G. Edan, A. Fromont, X. Gamé, O. Gout, C. Guillon, C. Harand, B. Jenny, P. Labauge, P.-H. Lalive, E. Le Page, P. Marque, L. Michel, X. Moisset, J.-C. Ouallet, O. Outteryck, F. Pelé, J. Pelletier, S. Pittion-Vouyovitch, A.-L. Ramelli, A. Ruet, E. Thouvenot, D. Veillard, C. Vignal-Clermont & S. Vukusic. 2017. La Sclérose en Plaques - Clinique et Thérapeutique. La Sclérose en Plaques - Clinique et Thérapeutique
3
78
.
Emanuele D’Amico, Carmela Leone, Tumani Hayrettin & Francesco Patti. (2016) Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. Multiple Sclerosis Journal 22:5, pages 581-589.
Crossref
Crossref
V. Planche, M. Gibelin, D. Cregut, B. Pereira & P. Clavelou. (2016) Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing−remitting, secondary progressive and primary progressive multiple sclerosis. European Journal of Neurology 23:2, pages 282-289.
Crossref
Crossref
M.P. Amato & B. Goretti. 2016. Translational Neuroimmunology in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis
365
384
.
J. D. Weisfeld-Adams, I. B. Katz Sand, J. M. Honce & F. D. Lublin. (2015) Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain 138:3, pages 517-539.
Crossref
Crossref
Eloi Magnin, Yoshimasa Sagawa Jr, Ludivine Chamard, Eric Berger, Thierry Moulin & Pierre Decavel. (2015) Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis. European Neurology 74:5-6, pages 243-250.
Crossref
Crossref
Aurélie Ruet. 2015. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases
227
247
.
Ronald A. CohenRonald A. Cohen. 2014. The Neuropsychology of Attention. The Neuropsychology of Attention
429
489
.
Jose M. Lafosse, Sandra M. Mitchell, John R. Corboy & Christopher M. Filley. (2013) The Nature of Verbal Memory Impairment in Multiple Sclerosis: A List-Learning and Meta-analytic Study. Journal of the International Neuropsychological Society 19:9, pages 995-1008.
Crossref
Crossref
Jenny Preston, Richard Hammersley & Helen Gallagher. (2013) The Executive Dysfunctions Most Commonly Associated with Multiple Sclerosis and Their Impact on Occupational Performance. British Journal of Occupational Therapy 76:5, pages 225-233.
Crossref
Crossref
Stephan Müller, Ralf Saur, Bernhard Greve, Arthur Melms, Martin Hautzinger, Andreas J Fallgatter & Thomas Leyhe. (2012) Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment. Multiple Sclerosis Journal 19:6, pages 799-805.
Crossref
Crossref
L. Messinis, M. H. Kosmidis, C. Vlahou, A. C. Malegiannaki, G. Gatzounis, N. Dimisianos, A. Karra, G. Kiosseoglou, P. Gourzis & P. Papathanasopoulos. (2013) Phonological Fluency Strategy of Switching Differentiates Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Patients. ISRN Neurology 2013, pages 1-7.
Crossref
Crossref
Ugo Nocentini, Silvia Romano & Carlo Caltagirone. 2012. Neuropsychiatric Dysfunction in Multiple Sclerosis. Neuropsychiatric Dysfunction in Multiple Sclerosis
133
153
.
Stanley Hawkins & Alastair Wilkins. 2013. Progressive Multiple Sclerosis. Progressive Multiple Sclerosis
11
30
.
C TurS PennyZ KhaleeliDR AltmannL CipolottiM RonAJ ThompsonO Ciccarelli. (2011) Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Multiple Sclerosis Journal 17:11, pages 1324-1332.
Crossref
Crossref
Laura J. Julian. (2011) Cognitive Functioning in Multiple Sclerosis. Neurologic Clinics 29:2, pages 507-525.
Crossref
Crossref
U. Nocentini, S. Romano & C. Caltagirone. 2010. I disturbi neuropsichiatrici nella sclerosi multipla. I disturbi neuropsichiatrici nella sclerosi multipla
123
144
.
S. PennyZ. KhaleeliL. CipolottiA. ThompsonM. Ron. (2010) Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology 74:7, pages 545-552.
Crossref
Crossref
Sandra Verena Müller, Sabine George, Helmut Hildebrandt, Thomas F. Münte, Paul Reuther, Karin Schoof-Tams & Claus-Werner Wallesch. (2010) Leitlinie zur Diagnostik und Therapie von exekutiven Dysfunktionen. Zeitschrift für Neuropsychologie 21:3, pages 167-176.
Crossref
Crossref
Nathalie Ehrlé & Audrey Henry. 2010. Neuropsychologie de la sclérose en plaques. Neuropsychologie de la sclérose en plaques
107
113
.
Nathalie Ehrlé. 2010. Neuropsychologie de la sclérose en plaques. Neuropsychologie de la sclérose en plaques
89
106
.
Bruno Brochet. 2010. Neuropsychologie de la sclérose en plaques. Neuropsychologie de la sclérose en plaques
59
70
.
M Ukkonen, T Vahvelainen, P Hämäläinen, P Dastidar & I Elovaara. (2009) Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study. Multiple Sclerosis Journal 15:9, pages 1055-1061.
Crossref
Crossref
A. J. Larner. 2009. Neuropsychological Neurology. Neuropsychological Neurology
157
177
.
Christopher Christodoulou, William S MacAllister, Nancy A McLinskey & Lauren B Krupp. (2008) Treatment of Cognitive Impairment in??Multiple Sclerosis. CNS Drugs 22:2, pages 87-97.
Crossref
Crossref
David H Miller & Siobhan M Leary. (2007) Primary-progressive multiple sclerosis. The Lancet Neurology 6:10, pages 903-912.
Crossref
Crossref
B. Brochet, M. Bonnet, M. Deloire, D. Hamel & E. Salort-Campana. (2007) Les troubles cognitifs au cours de la sclérose en plaques. Revue Neurologique 163:6-7, pages 697-702.
Crossref
Crossref
Alexander Winkelmann, Claudia Engel, Annett Apel & Uwe K. Zettl. (2007) Cognitive impairment in multiple sclerosis. Journal of Neurology 254:S2, pages II35-II42.
Crossref
Crossref
Pasquale Calabrese. (2006) Neuropsychology of multiple sclerosis. Journal of Neurology 253:S1, pages i10-i15.
Crossref
Crossref